In a dark coincidence, the researchers point to California's current catastrophe as a timely example of their recently published findings. "In that publication, fairly incredibly, we use the example ...

2024 was a breakthrough year for continuous glucose monitoring technology. Abbott and Dexcom introduced new CGM devices for type 2 adults who do not use insulin or for adults who have pre-diabetes.